1.13
Schlusskurs vom Vortag:
$1.09
Offen:
$1.09
24-Stunden-Volumen:
62,365
Relative Volume:
0.61
Marktkapitalisierung:
$8.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.42M
KGV:
-0.0145
EPS:
-78
Netto-Cashflow:
$-16.67M
1W Leistung:
+14.17%
1M Leistung:
-10.40%
6M Leistung:
-66.47%
1J Leistung:
-89.82%
Mustang Bio Inc Stock (MBIO) Company Profile
Firmenname
Mustang Bio Inc
Sektor
Branche
Telefon
(781) 652-4500
Adresse
95 SAWYER RD, WALTHAM, NY
Vergleichen Sie MBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MBIO
Mustang Bio Inc
|
1.13 | 7.96M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-10-02 | Eingeleitet | B. Riley FBR | Buy |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mustang Bio Inc Aktie (MBIO) Neueste Nachrichten
Is Mustang Bio Inc a good long term investmentMarket Sentiment Shifts & Learn to Think Like a Long-Term Investor - earlytimes.in
Support Zone Holds Steady for Jagran Prakashan Limited After DipLong-Term Investment Plans & Free Exceptional Risk Adjusted Gains - bollywoodhelpline.com
Is Mustang Bio Inc. stock near bottom after declineMarket Entry Points & Investment Risk Management Tips - bollywoodhelpline.com
Mustang Bio (NASDAQ:MBIO) versus Agios Pharmaceuticals (NASDAQ:AGIO) Critical Comparison - Defense World
Mustang Bio Shareholders Approve Equity Plans and Directors - TipRanks
Is Mustang Bio Inc. stock cheap at current valuation2025 Growth vs Value & Trade Opportunity Analysis - Улправда
Will Mustang Bio Inc. stock reach Wall Street targetsMarket Weekly Review & Accurate Buy Signal Notifications - Улправда
Market Pulse: Is Mustang Bio Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Volume Triggers - moha.gov.vn
Whale Trades: Why BKN stock stays resilientPortfolio Performance Report & Free Daily Entry Point Trade Alerts - moha.gov.vn
How Mustang Bio Inc. stock reacts to global recession fearsQuarterly Earnings Report & Long-Term Safe Investment Plans - Улправда
Macro Review: Will Mustang Bio Inc. stock gain from strong economyWatch List & AI Driven Stock Reports - moha.gov.vn
Will Mustang Bio Inc. stock deliver long term returnsExit Point & Weekly Breakout Stock Alerts - DonanımHaber
Will Mustang Bio Inc. stock deliver better than expected guidance2025 Key Highlights & AI Powered Market Entry Ideas - DonanımHaber
Quarterly Recap: How Mustang Bio Inc. stock reacts to global recession fearsJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Mustang Bio Earnings Notes - Trefis
Is GSPRD a good long term investmentRetail Trading Trends & Low Cost Wealth Building - earlytimes.in
Tech Rally: Can Mustang Bio Inc stock sustain revenue growthJuly 2025 Price Swings & Weekly High Return Stock Opportunities - BỘ NỘI VỤ
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN
Mustang Bio (MBIO) Stock Analysis Report | Financials & Insights - Benzinga
Mustang Bio (STU:2W60) Accounts Payable : €4.25 Mil (As of Sep. 2025) - GuruFocus
Can Mustang Bio Inc. stock sustain revenue growthJuly 2025 Setups & Daily Profit Focused Screening - moha.gov.vn
Mustang Bio Inc Stock Analysis and ForecastMomentum Stock Picks & Free Rapid Wealth Building - earlytimes.in
Why Mustang Bio Inc. stock attracts global investorsRate Hike & Consistent Income Trade Ideas - newser.com
Why Mustang Bio Inc. stock remains undervalued2025 Retail Activity & Safe Entry Zone Identification - newser.com
Will Mustang Bio Inc. stock benefit from upcoming earnings reportsJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
Why Mustang Bio Inc. stock is considered a top pickMarket Growth Report & Daily Volume Surge Signals - newser.com
Will Mustang Bio Inc. price bounce be sustainableMarket Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
Will Mustang Bio Inc. stock return to pre crisis levelsTrade Risk Assessment & Low Drawdown Investment Ideas - newser.com
Detecting price anomalies in Mustang Bio Inc. with AIJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Can Mustang Bio Inc. stock hit analyst price targetsTrade Volume Summary & Fast Entry and Exit Trade Plans - newser.com
Can Mustang Bio Inc. stock maintain operating marginsWeekly Trade Recap & Stock Portfolio Risk Management - newser.com
Smart tools for monitoring Mustang Bio Inc.’s price actionPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Can Mustang Bio Inc. stock deliver strong Q4 earningsMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
MBIOAI Stock Analysis - Meyka
How sustainable is Mustang Bio Inc. stock dividend payoutJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Is Mustang Bio Inc. stock affected by interest rate hikesMarket Performance Report & Growth Focused Investment Plans - newser.com
Is Mustang Bio Inc. still worth holding after the dipMarket Trend Summary & Stepwise Swing Trade Plans - newser.com
Will Mustang Bio Inc. stock see PE expansionPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Mustang Bio Inc. (MBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Finanzdaten der Mustang Bio Inc-Aktie (MBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):